A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
出版年份 2023 全文链接
标题
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
作者
关键词
-
出版物
Cancer Immunology Research
Volume 11, Issue 9, Pages 1237-1252
出版商
American Association for Cancer Research (AACR)
发表日期
2023-06-28
DOI
10.1158/2326-6066.cir-23-0189
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
- (2023) Roeland Lameris et al. Cell Reports Medicine
- Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
- (2022) José Saura-Esteller et al. Frontiers in Immunology
- A bispecific single domain antibody boosts autologous Vγ9Vδ2-T cell responses towards CD1d in chronic lymphocytic leukemia
- (2021) Iris de Weerdt et al. CLINICAL CANCER RESEARCH
- Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors
- (2021) Jim Middelburg et al. Cancers
- CAR-T cells and BiTEs in solid tumors: challenges and perspectives
- (2021) Julien Edeline et al. Journal of Hematology & Oncology
- Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
- (2020) Marc Rigau et al. SCIENCE
- GPA33: A Marker to Identify Stable Human Regulatory T Cells
- (2020) Rianne Opstelten et al. JOURNAL OF IMMUNOLOGY
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Antigen-Presenting Cell Characteristics of Human γδ T Lymphocytes in Chronic Myeloid Leukemia
- (2018) Piamsiri Sawaisorn et al. IMMUNOLOGICAL INVESTIGATIONS
- The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
- (2018) Daisy Melandri et al. NATURE IMMUNOLOGY
- CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
- (2018) Kerstin Schütze et al. Frontiers in Immunology
- Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL
- (2017) J Duell et al. LEUKEMIA
- The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker
- (2017) Nicolas Williet et al. Oncotarget
- Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
- (2017) Marie Tosolini et al. OncoImmunology
- A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
- (2017) Renée C. G. de Bruin et al. OncoImmunology
- Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications
- (2016) Renée C.G. de Bruin et al. CLINICAL IMMUNOLOGY
- Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features
- (2016) Roeland Lameris et al. IMMUNOLOGY
- CD8αβ+γδ T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease
- (2016) Mohammad Kadivar et al. JOURNAL OF IMMUNOLOGY
- Evolution and function of the TCR Vgamma9 chain repertoire: It’s good to be public
- (2015) C. David Pauza et al. CELLULAR IMMUNOLOGY
- Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia
- (2015) Jingjing Wu et al. Journal of Hematology & Oncology
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
- (2013) Karl R. Schmitz et al. STRUCTURE
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
- (2012) Adriana Cordova et al. PLoS One
- Human MAIT and CD8 cells develop from a pool of type-17 precommitted CD8+ T cells
- (2011) L. J. Walker et al. BLOOD
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
- (2010) Daiko Wakita et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
- (2010) Ralf Lutterbuese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Efficient Killing of Human Colon Cancer Stem Cells by T Lymphocytes
- (2009) M. Todaro et al. JOURNAL OF IMMUNOLOGY
- Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
- (2009) Nichole L. Bryant et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation